LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

Search

Boston Scientific Corp.

Open

Sector Healthcare

76.29 0.3

Overview

Share price change

24h

Current

Min

75.61

Max

76.48

Key metrics

By Trading Economics

Income

-12M

492M

Sales

135M

3.9B

P/E

Sector Avg

70.871

23.904

EPS

0.56

Profit margin

12.746

Employees

48,000

EBITDA

-27M

981M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+8.05 upside

Dividends

By Dow Jones

Next Earnings

25 lip 2024

Market Stats

By TradingEconomics

Market Cap

2.3B

113B

Previous open

75.99

Previous close

76.29

News Sentiment

By Acuity

67%

33%

318 / 370 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Boston Scientific Corp. Chart

Related News

18 cze 2024, 13:23 UTC

Acquisitions, Mergers, Takeovers

Correction to Boston Scientific to Buy Silk Road Article

18 cze 2024, 11:41 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18 cze 2024, 11:31 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24 kwi 2024, 11:01 UTC

Earnings

Boston Scientific Lifts 2024 Outlook After Strong 1Q

4 kwi 2024, 12:00 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information

18 cze 2024, 20:22 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 cze 2024, 14:25 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 cze 2024, 12:54 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 cze 2024, 11:33 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18 cze 2024, 11:18 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18 cze 2024, 11:03 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18 cze 2024, 11:02 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18 cze 2024, 11:01 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18 cze 2024, 11:01 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18 cze 2024, 11:00 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24 kwi 2024, 12:30 UTC

Top News
Earnings

Boston Scientific Stock Rises on More Than Just an Earnings Beat -- Barrons.com

24 kwi 2024, 10:36 UTC

Earnings

Boston Scientific Sees 2024 Sales Up 11%-13%, Organic Sales Up 10%-12% >BSX

24 kwi 2024, 10:35 UTC

Earnings

Boston Scientific Sees 2Q Sales Up 10.5%-12.5%, Organic Sales Up 10%-12% >BSX

24 kwi 2024, 10:31 UTC

Earnings

Boston Scientific Sees 2024 Adj EPS $2.29-Adj EPS $2.34 >BSX

24 kwi 2024, 10:31 UTC

Earnings

Boston Scientific Sees 2024 EPS $1.43-EPS $1.48 >BSX

24 kwi 2024, 10:31 UTC

Earnings

Boston Scientific Sees 2Q Adj EPS 57c-Adj EPS 59c >BSX

24 kwi 2024, 10:31 UTC

Earnings

Boston Scientific Sees 2Q EPS 35c-EPS 37c >BSX

24 kwi 2024, 10:31 UTC

Earnings

Boston Scientific 1Q Adj EPS 56c >BSX

24 kwi 2024, 10:31 UTC

Earnings

Boston Scientific 1Q Sales $3.86B >BSX

24 kwi 2024, 10:31 UTC

Earnings

Boston Scientific 1Q EPS 33c >BSX

4 kwi 2024, 11:25 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Now Sees Mereger Closing in 2H of 2024 >BSX

4 kwi 2024, 11:24 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific, Axionics Expect to Promptly Respond to Second Request >BSX

4 kwi 2024, 11:24 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific, Axonics Receive Request for Additional Info From FTC Regarding Merger >BSX

31 sty 2024, 14:19 UTC

Earnings

Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance -- IBD

31 sty 2024, 12:59 UTC

Earnings

Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts -- IBD

Peer Comparison

Price change

Boston Scientific Corp. Forecast

Price Target

By TipRanks

8.05% upside

12 Months Forecast

Average 82.45 USD  8.05%

High 95 USD

Low 72 USD

Based on 22 Wall Street analysts offering 12 month price targets forBoston Scientific Corp. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

22 ratings

21

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

75.92 / 77.555Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

318 / 370 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.